Brussels, 7 May 2025
The European Commission has approved, under the European Merger Regulation, the acquisition of joint control of Sterimed International SAS (“Sterimed”) by Sagard SAS, both based in France, and IK Investment Partners AIFM (“IK Partners”), based in Luxembourg.
The transaction mainly concerns the manufacturing and supply of medical packaging.
The Commission concluded that the proposed merger would not raise competition concerns, given the negligible activities of the joint venture in the European Economic Area and the limited market positions of the companies concerned resulting from the proposed transaction. The transaction was examined under the simplified merger control procedure.
More information is available on the Commission’s competition website , in the public case register under case number M.11927.